Barclays maintains Alpha Tau Medical at Overweight, raises PT to $30
Barclays kept Alpha Tau Medical at Overweight and raised its price target to $30.00 per share from $17.00, according to Benzinga.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.